|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 19, 2014 ) Dallas, TX -- Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cancer deaths worldwide, and the incidence of lung cancer is increasing significantly. Lung cancer is the common cause of mortality and morbidity not only in developed countries but also in developing countries. One of the most common types of lung cancer is non-small cell lung cancer. It grows and spreads quite slowly. Smoking is considered as a major cause of lung cancer, although lung cancer also occurs in non-smokers. There are three main types of non-small cell lung cancer: squamous cell (epidermoid) carcinoma, adenocarcinoma, and large cell (undifferentiated) carcinoma. Some of the common symptoms associated with non-small cell lung cancer are chest pain, a cough that does not go away, coughing up blood, fatigue, loss of appetite, losing weight without trying, shortness of breath, and wheezing.
Analysts forecast the Global Non-small Cell Lung Cancer market to grow at a CAGR of 3.62 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Non-small Cell Lung Cancer market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through various therapies adopted for the treatment of non-small cell lung cancer, including
Biologics
Small Molecules
Global Non-small Cell Lung Cancer Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Non-small Cell Lung Cancer market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Buy a copy of this report @http://www.rnrmarketresearch.com/contacts/purchase?rname=211709 .
Key Regions
Americas
APAC
EMEA
Key Vendors
AstraZeneca
Celgene
Eli Lilly
F. Hoffmann-La Roche
Pfizer
Other Prominent Vendors
Aetna
Boehringer Ingelheim
Celldex
Eisai
GlaxoSmithKline
IMClone
Merck Serono
Novartis
Qiagen
OncoGenex
OSI Pharmaceuticals
Pierre Fabre
Sanofi
Synta
Market Driver
High Unmet Needs
For a full, detailed list, view our report
Market Challenge
High Cost of Therapy
For a full, detailed list, view our report
Market Trend
Availability of Personalized Medicine
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Single User License is US $2500 for Discount Inquire@ http://www.rnrmarketresearch.com/contacts/discount?rname=211709 .
About us:Rnrmarketresearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
RnR Market Research
Ritesh Tiwari
+ 1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
